查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1266534

全球基因合成市场：按方法、按最终用户：机会分析和行业预测，2021-2031 年

Gene Synthesis Market By Method, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格

预计2021年全球基因合成市场规模为11.1亿美元，2031年销售额为59.79亿美元，复合年增长率为18.4%。

基因合成是一种创造或生产人工基因的科学方法。 基因合成是指使用旨在从核甘酸组装和构建基因的各种方法来创建基因的过程。 核甘酸是製造核酸过程中必不可少的组成部分。

实际上，RNA 和 DNA 是由很长的核甘酸序列组成的。 这些化学物质由附着在含有磷酸盐和氮的碱基上的糖分子组成。 基因合成技术使科学家和研究人员能够精确指定和定制所需的序列。

老年人口的增加、慢性病发病率的上升、具有成本效益的治疗以及对新型疫苗的需求增加是预计将推动基因合成市场增长的一些主要因素。 随着传染病在世界范围内蔓延，对有效治疗方法和疫苗的需求增加，促使研究人员和科学家加快研究工作，寻找治疗癌症和肿瘤等疾病的有效方法。我不得不创造它。 某些疾病可以用化学药物和生物疗法（如基因疗法）有效治疗。 基因组学的应用加强了地方病和传染病的治疗。 我们还可以更好地了解新的耐药性并确定疫苗和新药的潜在目标。 基因疗法在感染性疾病的治疗中引起了许多研究者的兴趣，因为它可以通过重组DNA技术、DNA&RNA核□、单链抗体等进行治疗。

随着基因治疗技术的快速发展，患者基因插入和基因治疗需要更先进的技术和经验丰富的人力资源。 在整个预测期内，大多数医疗保健专业人员无法进行治疗可能会对基因合成市场产生负面影响。

政府加大对涉及新基因合成的研究的支持，提高疗效，以及研究人员、科学家、製药和生物技术公司加大研发力度，预计将推动未来的市场增长。 此外，确保每个人都能从新开发技术的治疗中受益的报销政策有望在未来几年加速市场增长。 这促进了基因合成市场的增长。

COVID-19 大流行正以积极和消极的方式影响基因合成行业。 在大流行初期，2019冠状病毒病（COVID-19）对材料供应、生产和物流运营构成了重大挑战，对细胞和基因治疗（CGT）业务产生了重大影响。 当 COVID-19 疫情开始时，全球大多数公司和研究机构都关闭了，减少了基因合成仪的市场需求和实验室使用。

COVID-19 疫情为基因合成业务提供了巨大的增长潜力。 基因合成是一个具有未知潜力的主题，它支持市场在创收方面的增长。

内容

第一章介绍

第 2 章执行摘要

第 3 章市场概述

  • 市场定义和范围
  • 主要发现
    • 顶级影响因子
    • 顶级投资基金
  • 波特的五力分析
  • 市场动态
    • 司机
    • 约束因素
    • 机会
  • 分析 COVID-19 对市场的影响
  • 关键法规分析
  • 市场份额分析
  • 专利情况
  • 监管准则
  • 价值链分析

第 4 章基因合成市场：按方法分类

  • 概览
    • 市场规模和预测
  • 固相合成
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 通过 PCR 方法合成□
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 通过 CHIP 合成 DNA
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析

第 5 章基因合成市场：最终用户

  • 概览
    • 市场规模和预测
  • 学术和研究机构，
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 生物技术和製药公司，
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 诊断实验室
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 其他
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析

第 6 章基因合成市场：按地区

  • 概览
    • 市场规模和预测：按地区
  • 北美
    • 主要趋势和机遇
    • 市场规模/预测：按方法
    • 市场规模和预测：按最终用户分类
    • 市场规模/预测：按国家/地区分类
      • 美国
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按方法
      • 市场规模和预测：按最终用户分类
      • 加拿大
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按方法
      • 市场规模和预测：按最终用户分类
      • 墨西哥
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按方法
      • 市场规模和预测：按最终用户分类
  • 欧洲
    • 主要趋势和机遇
    • 市场规模/预测：按方法
    • 市场规模和预测：按最终用户分类
    • 市场规模/预测：按国家/地区分类
      • 英国
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按方法
      • 市场规模和预测：按最终用户分类
      • 德国
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按方法
      • 市场规模和预测：按最终用户分类
      • 法国
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按方法
      • 市场规模和预测：按最终用户分类
      • 西班牙
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按方法
      • 市场规模和预测：按最终用户分类
      • 意大利
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按方法
      • 市场规模和预测：按最终用户分类
      • 其他欧洲
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按方法
      • 市场规模和预测：按最终用户分类
  • 亚太地区
    • 主要趋势和机遇
    • 市场规模/预测：按方法
    • 市场规模和预测：按最终用户分类
    • 市场规模/预测：按国家/地区分类
      • 中国
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按方法
      • 市场规模和预测：按最终用户分类
      • 印度
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按方法
      • 市场规模和预测：按最终用户分类
      • 日本
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按方法
      • 市场规模和预测：按最终用户分类
      • 韩国
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按方法
      • 市场规模和预测：按最终用户分类
      • 澳大利亚
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按方法
      • 市场规模和预测：按最终用户分类
      • 其他亚太地区
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按方法
      • 市场规模和预测：按最终用户分类
  • 拉美
    • 主要趋势和机遇
    • 市场规模/预测：按方法
    • 市场规模和预测：按最终用户分类
    • 市场规模/预测：按国家/地区分类
      • 巴西
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按方法
      • 市场规模和预测：按最终用户分类
      • 沙特阿拉伯
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按方法
      • 市场规模和预测：按最终用户分类
      • 阿联酋
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按方法
      • 市场规模和预测：按最终用户分类
      • 南非
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按方法
      • 市场规模和预测：按最终用户分类
      • LAMEA 的其余部分
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按方法
      • 市场规模和预测：按最终用户分类

第七章竞争格局

  • 介绍
  • 关键成功策略
  • 10 家主要公司的产品映射
  • 比赛仪表板
  • 竞争热图
  • 定位顶级公司，2021 年

第八章公司简介

  • Genscript Technology
  • Brooks Automation, Inc.
  • Boster Biological Technology
  • Twist Bioscience
  • Codex DNA
  • Biomatik
  • promab biotechnologies, inc.
  • Thermo Fisher Scientific, Inc.
  • Integrated DNA Technologies, Inc.
  • OriGene Technologies, Inc.
Product Code: A39015

The global gene synthesis market size was $1,110 million in 2021 and is predicted to grow with a CAGR of 18.4%, by generating a revenue of $5,979 million by 2031.

Gene synthesis is the scientific method for generating or producing artificial genes. Gene synthesis refers to the process by which genes are created using various ways aimed at assembling and constructing genes from nucleotides. Nucleotide is an essential building block in the process of creating nucleic acid. 

In reality, RNA and DNA are made up of lengthy sequences of nucleotides. These chemicals are made up of sugar molecules coupled to a phosphate and a nitrogen-containing base. The gene synthesis technique enables scientists and researchers to precisely specify and tailor the desired sequence. 

The increase in the geriatric population, rise in the incidence of chronic illnesses, cost-effective treatment, and increase in demand for novel vaccines are some of the primary factors anticipated to drive the gene synthesis market growth. Because of the rising prevalence of infectious diseases around the world, the demand for effective treatments and vaccines has increased, prompting researchers and scientists to accelerate their research efforts and produce effective treatment options for diseases such as cancer and tumors. Certain illnesses can be effectively treated with chemical drugs and biological treatments, such as gene therapy. The application of genomics has enhanced the treatment of endemic and infectious diseases. It also allows us to better understand new drug resistance and identify possible targets for vaccines and new medicines. Gene therapy has piqued the interest of many researchers for the treatment of infectious diseases since it can be treated with recombinant DNA technology, DNA & RNA ribozyme, and single chain antibodies.  

The rapid evolution of the technology involved in gene therapy necessitates increased skill work and experienced individuals for the insertion of genes or the execution of gene therapy procedures in patients. Most healthcare professionals' inability to carry out the therapy may have a negative impact on the gene synthesis market throughout the forecast period. 

Increase in government support for the research involving synthesis of new genes,  rise in therapy efficiency, and growth in research and development by the researchers, scientists, and pharmaceutical & biotechnological companies is expected to drive the market growth in the future. In addition, the market growth is expected to boost in the coming years owing to reimbursement policies so that every individual can benefit from the treatment of new technologies developed. This contributes to the rise in the gene synthesis market. 

The COVID-19 pandemic has had an impact on the gene synthesis industry, both positively and negatively. During the initial phase of the pandemic, the coronavirus 2019 (COVID-19), which has caused significant challenges in the supply of materials, production, and logistical operations, significantly impacted the cell and gene therapy (CGT) business. When the COVID-19 pandemic began, most businesses and research initiatives around the world suspended operations, reducing market demand for gene synthesizers and their use in laboratories. 

The spread of the COVID-19 pandemic has aided the gene synthesis business by creating enormous growth possibilities. The topic of gene synthesis is being investigated for undiscovered potential, which is supporting the growth of the market in terms of revenue creation. 

The key players profiled in this report include: Genscript Biotech Corporation, Thermo Fisher Scientific, Inc., Brooks Automation, Inc., Boster Biological Technology, Twist Bioscience Corporation, Danaher Corporation, Biomatik Corporation, ProteoGenix, ProMab Biotechnologies, Inc., and OriGene Technologies, Inc. 

The gene synthesis market is segmented on the basis of method, end user, and region. As per method, the market has been divided into solid phase synthesis, PCR-based enzyme synthesis, and CHIP-based DNA synthesis. By end user, the market has been classified into academic and research institutes, biotech and pharmaceutical companies, diagnostic laboratories, and other. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the gene synthesis market analysis from 2021 to 2031 to identify the prevailing gene synthesis market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the gene synthesis market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global gene synthesis market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Method

  • Solid Phase Synthesis
  • PCR Based Enzyme Synthesis
  • CHIP Based DNA Synthesis

By End User

  • Biotech and Pharmaceutical Companies,
  • Diagnostic Laboratories
  • Academic and Research Institutes,
  • Other

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of LAMEA

Key Market Players

  • Brooks Automation, Inc.
  • Boster Biological Technology
  • Twist Bioscience
  • Codex DNA
  • Biomatik
  • promab biotechnologies, inc.
  • Thermo Fisher Scientific, Inc.
  • Genscript Technology
  • Integrated DNA Technologies, Inc.
  • OriGene Technologies, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. COVID-19 Impact Analysis on the market
  • 3.6. Key Regulation Analysis
  • 3.7. Market Share Analysis
  • 3.8. Patent Landscape
  • 3.9. Regulatory Guidelines
  • 3.10. Value Chain Analysis

CHAPTER 4: GENE SYNTHESIS MARKET, BY METHOD

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Solid Phase Synthesis
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. PCR Based Enzyme Synthesis
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. CHIP Based DNA Synthesis
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: GENE SYNTHESIS MARKET, BY END USER

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Academic and Research Institutes,
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Biotech and Pharmaceutical Companies,
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Diagnostic Laboratories
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Other
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: GENE SYNTHESIS MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key trends and opportunities
    • 6.2.2. Market size and forecast, by Method
    • 6.2.3. Market size and forecast, by End User
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Key market trends, growth factors and opportunities
      • 6.2.4.1.2. Market size and forecast, by Method
      • 6.2.4.1.3. Market size and forecast, by End User
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Key market trends, growth factors and opportunities
      • 6.2.4.2.2. Market size and forecast, by Method
      • 6.2.4.2.3. Market size and forecast, by End User
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Key market trends, growth factors and opportunities
      • 6.2.4.3.2. Market size and forecast, by Method
      • 6.2.4.3.3. Market size and forecast, by End User
  • 6.3. Europe
    • 6.3.1. Key trends and opportunities
    • 6.3.2. Market size and forecast, by Method
    • 6.3.3. Market size and forecast, by End User
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. UK
      • 6.3.4.1.1. Key market trends, growth factors and opportunities
      • 6.3.4.1.2. Market size and forecast, by Method
      • 6.3.4.1.3. Market size and forecast, by End User
      • 6.3.4.2. Germany
      • 6.3.4.2.1. Key market trends, growth factors and opportunities
      • 6.3.4.2.2. Market size and forecast, by Method
      • 6.3.4.2.3. Market size and forecast, by End User
      • 6.3.4.3. France
      • 6.3.4.3.1. Key market trends, growth factors and opportunities
      • 6.3.4.3.2. Market size and forecast, by Method
      • 6.3.4.3.3. Market size and forecast, by End User
      • 6.3.4.4. Spain
      • 6.3.4.4.1. Key market trends, growth factors and opportunities
      • 6.3.4.4.2. Market size and forecast, by Method
      • 6.3.4.4.3. Market size and forecast, by End User
      • 6.3.4.5. Italy
      • 6.3.4.5.1. Key market trends, growth factors and opportunities
      • 6.3.4.5.2. Market size and forecast, by Method
      • 6.3.4.5.3. Market size and forecast, by End User
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Key market trends, growth factors and opportunities
      • 6.3.4.6.2. Market size and forecast, by Method
      • 6.3.4.6.3. Market size and forecast, by End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key trends and opportunities
    • 6.4.2. Market size and forecast, by Method
    • 6.4.3. Market size and forecast, by End User
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. China
      • 6.4.4.1.1. Key market trends, growth factors and opportunities
      • 6.4.4.1.2. Market size and forecast, by Method
      • 6.4.4.1.3. Market size and forecast, by End User
      • 6.4.4.2. India
      • 6.4.4.2.1. Key market trends, growth factors and opportunities
      • 6.4.4.2.2. Market size and forecast, by Method
      • 6.4.4.2.3. Market size and forecast, by End User
      • 6.4.4.3. Japan
      • 6.4.4.3.1. Key market trends, growth factors and opportunities
      • 6.4.4.3.2. Market size and forecast, by Method
      • 6.4.4.3.3. Market size and forecast, by End User
      • 6.4.4.4. South Korea
      • 6.4.4.4.1. Key market trends, growth factors and opportunities
      • 6.4.4.4.2. Market size and forecast, by Method
      • 6.4.4.4.3. Market size and forecast, by End User
      • 6.4.4.5. Australia
      • 6.4.4.5.1. Key market trends, growth factors and opportunities
      • 6.4.4.5.2. Market size and forecast, by Method
      • 6.4.4.5.3. Market size and forecast, by End User
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Key market trends, growth factors and opportunities
      • 6.4.4.6.2. Market size and forecast, by Method
      • 6.4.4.6.3. Market size and forecast, by End User
  • 6.5. LAMEA
    • 6.5.1. Key trends and opportunities
    • 6.5.2. Market size and forecast, by Method
    • 6.5.3. Market size and forecast, by End User
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Key market trends, growth factors and opportunities
      • 6.5.4.1.2. Market size and forecast, by Method
      • 6.5.4.1.3. Market size and forecast, by End User
      • 6.5.4.2. Saudi Arabia
      • 6.5.4.2.1. Key market trends, growth factors and opportunities
      • 6.5.4.2.2. Market size and forecast, by Method
      • 6.5.4.2.3. Market size and forecast, by End User
      • 6.5.4.3. UAE
      • 6.5.4.3.1. Key market trends, growth factors and opportunities
      • 6.5.4.3.2. Market size and forecast, by Method
      • 6.5.4.3.3. Market size and forecast, by End User
      • 6.5.4.4. South Africa
      • 6.5.4.4.1. Key market trends, growth factors and opportunities
      • 6.5.4.4.2. Market size and forecast, by Method
      • 6.5.4.4.3. Market size and forecast, by End User
      • 6.5.4.5. Rest of LAMEA
      • 6.5.4.5.1. Key market trends, growth factors and opportunities
      • 6.5.4.5.2. Market size and forecast, by Method
      • 6.5.4.5.3. Market size and forecast, by End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top player positioning, 2021

CHAPTER 8: COMPANY PROFILES

  • 8.1. Genscript Technology
    • 8.1.1. Company overview
    • 8.1.2. Key Executives
    • 8.1.3. Company snapshot
  • 8.2. Brooks Automation, Inc.
    • 8.2.1. Company overview
    • 8.2.2. Key Executives
    • 8.2.3. Company snapshot
  • 8.3. Boster Biological Technology
    • 8.3.1. Company overview
    • 8.3.2. Key Executives
    • 8.3.3. Company snapshot
  • 8.4. Twist Bioscience
    • 8.4.1. Company overview
    • 8.4.2. Key Executives
    • 8.4.3. Company snapshot
  • 8.5. Codex DNA
    • 8.5.1. Company overview
    • 8.5.2. Key Executives
    • 8.5.3. Company snapshot
  • 8.6. Biomatik
    • 8.6.1. Company overview
    • 8.6.2. Key Executives
    • 8.6.3. Company snapshot
  • 8.7. promab biotechnologies, inc.
    • 8.7.1. Company overview
    • 8.7.2. Key Executives
    • 8.7.3. Company snapshot
  • 8.8. Thermo Fisher Scientific, Inc.
    • 8.8.1. Company overview
    • 8.8.2. Key Executives
    • 8.8.3. Company snapshot
  • 8.9. Integrated DNA Technologies, Inc.
    • 8.9.1. Company overview
    • 8.9.2. Key Executives
    • 8.9.3. Company snapshot
  • 8.10. OriGene Technologies, Inc.
    • 8.10.1. Company overview
    • 8.10.2. Key Executives
    • 8.10.3. Company snapshot

LIST OF TABLES

  • TABLE 01. GLOBAL GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 02. GENE SYNTHESIS MARKET FOR SOLID PHASE SYNTHESIS, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 03. GENE SYNTHESIS MARKET FOR PCR BASED ENZYME SYNTHESIS, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 04. GENE SYNTHESIS MARKET FOR CHIP BASED DNA SYNTHESIS, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 05. GLOBAL GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 06. GENE SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES,, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 07. GENE SYNTHESIS MARKET FOR BIOTECH AND PHARMACEUTICAL COMPANIES,, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 08. GENE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 09. GENE SYNTHESIS MARKET FOR OTHER, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 10. GENE SYNTHESIS MARKET, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 11. NORTH AMERICA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 12. NORTH AMERICA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 13. NORTH AMERICA GENE SYNTHESIS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 14. U.S. GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 15. U.S. GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 16. CANADA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 17. CANADA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 18. MEXICO GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 19. MEXICO GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 20. EUROPE GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 21. EUROPE GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 22. EUROPE GENE SYNTHESIS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 23. UK GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 24. UK GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 25. GERMANY GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 26. GERMANY GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 27. FRANCE GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 28. FRANCE GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 29. SPAIN GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 30. SPAIN GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 31. ITALY GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 32. ITALY GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 33. REST OF EUROPE GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 34. REST OF EUROPE GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 35. ASIA-PACIFIC GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 36. ASIA-PACIFIC GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 37. ASIA-PACIFIC GENE SYNTHESIS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 38. CHINA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 39. CHINA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 40. INDIA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 41. INDIA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 42. JAPAN GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 43. JAPAN GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 44. SOUTH KOREA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 45. SOUTH KOREA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 46. AUSTRALIA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 47. AUSTRALIA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 48. REST OF ASIA-PACIFIC GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 49. REST OF ASIA-PACIFIC GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 50. LAMEA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 51. LAMEA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 52. LAMEA GENE SYNTHESIS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 53. BRAZIL GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 54. BRAZIL GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 55. SAUDI ARABIA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 56. SAUDI ARABIA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 57. UAE GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 58. UAE GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 59. SOUTH AFRICA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 60. SOUTH AFRICA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 61. REST OF LAMEA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 62. REST OF LAMEA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 63. GENSCRIPT TECHNOLOGY: KEY EXECUTIVES
  • TABLE 64. GENSCRIPT TECHNOLOGY: COMPANY SNAPSHOT
  • TABLE 65. BROOKS AUTOMATION, INC.: KEY EXECUTIVES
  • TABLE 66. BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT
  • TABLE 67. BOSTER BIOLOGICAL TECHNOLOGY: KEY EXECUTIVES
  • TABLE 68. BOSTER BIOLOGICAL TECHNOLOGY: COMPANY SNAPSHOT
  • TABLE 69. TWIST BIOSCIENCE: KEY EXECUTIVES
  • TABLE 70. TWIST BIOSCIENCE: COMPANY SNAPSHOT
  • TABLE 71. CODEX DNA: KEY EXECUTIVES
  • TABLE 72. CODEX DNA: COMPANY SNAPSHOT
  • TABLE 73. BIOMATIK: KEY EXECUTIVES
  • TABLE 74. BIOMATIK: COMPANY SNAPSHOT
  • TABLE 75. PROMAB BIOTECHNOLOGIES, INC.: KEY EXECUTIVES
  • TABLE 76. PROMAB BIOTECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • TABLE 77. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
  • TABLE 78. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • TABLE 79. INTEGRATED DNA TECHNOLOGIES, INC.: KEY EXECUTIVES
  • TABLE 80. INTEGRATED DNA TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • TABLE 81. ORIGENE TECHNOLOGIES, INC.: KEY EXECUTIVES
  • TABLE 82. ORIGENE TECHNOLOGIES, INC.: COMPANY SNAPSHOT

LIST OF FIGURES

  • FIGURE 01. GENE SYNTHESIS MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF GENE SYNTHESIS MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN GENE SYNTHESIS MARKET (2022-2031)
  • FIGURE 04. PORTER FIVE-1
  • FIGURE 05. PORTER FIVE-2
  • FIGURE 06. PORTER FIVE-3
  • FIGURE 07. PORTER FIVE-4
  • FIGURE 08. PORTER FIVE-5
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALGENE SYNTHESIS MARKET
  • FIGURE 10. IMPACT OF KEY REGULATION: GENE SYNTHESIS MARKET
  • FIGURE 11. MARKET SHARE ANALYSIS: GENE SYNTHESIS MARKET
  • FIGURE 12. PATENT ANALYSIS BY COMPANY
  • FIGURE 13. PATENT ANALYSIS BY COUNTRY
  • FIGURE 14. REGULATORY GUIDELINES: GENE SYNTHESIS MARKET
  • FIGURE 15. VALUE CHAIN ANALYSIS: GENE SYNTHESIS MARKET
  • FIGURE 16. GENE SYNTHESIS MARKET, BY METHOD, 2021(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR SOLID PHASE SYNTHESIS, BY COUNTRY 2021-2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR PCR BASED ENZYME SYNTHESIS, BY COUNTRY 2021-2031(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR CHIP BASED DNA SYNTHESIS, BY COUNTRY 2021-2031(%)
  • FIGURE 20. GENE SYNTHESIS MARKET, BY END USER, 2021(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES,, BY COUNTRY 2021-2031(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR BIOTECH AND PHARMACEUTICAL COMPANIES,, BY COUNTRY 2021-2031(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY 2021-2031(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR OTHER, BY COUNTRY 2021-2031(%)
  • FIGURE 25. GENE SYNTHESIS MARKET BY REGION, 2021
  • FIGURE 26. U.S. GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 27. CANADA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 28. MEXICO GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 29. UK GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 30. GERMANY GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 31. FRANCE GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 32. SPAIN GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 33. ITALY GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 34. REST OF EUROPE GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 35. CHINA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 36. INDIA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 37. JAPAN GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 38. SOUTH KOREA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 39. AUSTRALIA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 40. REST OF ASIA-PACIFIC GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 41. BRAZIL GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 42. SAUDI ARABIA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 43. UAE GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 44. SOUTH AFRICA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 45. REST OF LAMEA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 49. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 50. COMPETITIVE DASHBOARD
  • FIGURE 51. COMPETITIVE HEATMAP: GENE SYNTHESIS MARKET
  • FIGURE 52. TOP PLAYER POSITIONING, 2021